Nautilus Biotechnology, Inc. (NAUT)
2.17
-0.26
(-10.70%)
USD |
NASDAQ |
Nov 19, 16:00
2.20
+0.03
(+1.38%)
After-Hours: 04:19
Nautilus Biotechnology Price : 2.17 for Nov. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | 2.44 | 2.55 | 2.10 | 2.17 | 3.389M |
| Nov 18, 2026 | 2.34 | 2.55 | 2.31 | 2.43 | 4.554M |
| Nov 17, 2026 | 2.16 | 2.445 | 2.14 | 2.36 | 4.018M |
| Nov 16, 2026 | 2.25 | 2.315 | 2.10 | 2.10 | 4.158M |
| Nov 13, 2026 | 2.39 | 2.400 | 2.205 | 2.32 | 1.882M |
| Nov 12, 2026 | 2.405 | 2.46 | 2.24 | 2.38 | 3.318M |
| Nov 11, 2026 | 2.38 | 2.54 | 2.351 | 2.42 | 3.731M |
| Nov 10, 2026 | 2.30 | 2.35 | 2.18 | 2.32 | 3.279M |
| Nov 09, 2026 | 2.23 | 2.435 | 2.16 | 2.38 | 4.102M |
| Nov 06, 2026 | 2.18 | 2.29 | 2.055 | 2.23 | 4.554M |
| Nov 05, 2026 | 2.24 | 2.245 | 1.99 | 2.15 | 7.619M |
| Nov 04, 2026 | 2.315 | 2.39 | 2.15 | 2.29 | 6.459M |
| Nov 03, 2026 | 2.40 | 2.55 | 2.315 | 2.35 | 4.792M |
| Nov 02, 2026 | 2.74 | 2.754 | 2.27 | 2.335 | 7.309M |
| Oct 30, 2026 | 2.88 | 3.08 | 2.64 | 2.73 | 8.069M |
| Oct 29, 2026 | 3.22 | 3.42 | 3.08 | 3.14 | 7.509M |
| Oct 28, 2026 | 3.00 | 3.34 | 2.80 | 3.21 | 15.15M |
| Oct 27, 2026 | 2.34 | 3.02 | 2.171 | 2.89 | 20.70M |
| Oct 26, 2026 | 3.145 | 3.18 | 2.23 | 2.44 | 16.59M |
| Oct 23, 2026 | 2.58 | 3.26 | 2.57 | 3.24 | 13.79M |
| Oct 22, 2026 | 2.72 | 2.86 | 2.535 | 2.60 | 6.912M |
| Oct 21, 2026 | 2.50 | 2.83 | 2.50 | 2.71 | 8.656M |
| Oct 20, 2026 | 2.615 | 2.71 | 2.38 | 2.55 | 10.02M |
| Oct 19, 2026 | 2.03 | 2.68 | 1.97 | 2.63 | 14.97M |
| Oct 16, 2026 | 2.17 | 2.230 | 1.99 | 2.06 | 6.455M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agilent Technologies, Inc. | 175.34 |
| Bio-Rad Laboratories, Inc. | 367.50 |
| Bruker Corp. | 62.10 |
| Danaher Corp. | 227.56 |
| Harvard Bioscience, Inc. | 8.68 |
Price Related Metrics
| PS Ratio | 649.18 |
| Price to Book Value | 2.370 |
| Earnings Yield | -21.28% |
| Market Cap | 276.30M |